Atossa Genetics Inc. closed its public offering of 5.3 million common shares at 27 cents apiece.
The company also closed its concurrent private placement where it issued and sold class A and class B warrants, exercisable for 10.6 million common shares, at 31.5 cents per share.
The warrants are exercisable starting six months from issuance. The class A and B warrants will expire eight months and 12 months after the initial issuance date, respectively.
Maxim Group LLC acted as sole placement agent for the offering.